1. Home
  2. RVMD vs VNT Comparison

RVMD vs VNT Comparison

Compare RVMD & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • VNT
  • Stock Information
  • Founded
  • RVMD 2014
  • VNT 2019
  • Country
  • RVMD United States
  • VNT United States
  • Employees
  • RVMD N/A
  • VNT N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • VNT Industrial Machinery/Components
  • Sector
  • RVMD Health Care
  • VNT Industrials
  • Exchange
  • RVMD Nasdaq
  • VNT Nasdaq
  • Market Cap
  • RVMD 7.5B
  • VNT 6.2B
  • IPO Year
  • RVMD 2020
  • VNT N/A
  • Fundamental
  • Price
  • RVMD $65.84
  • VNT $37.44
  • Analyst Decision
  • RVMD Strong Buy
  • VNT Strong Buy
  • Analyst Count
  • RVMD 17
  • VNT 9
  • Target Price
  • RVMD $77.24
  • VNT $46.88
  • AVG Volume (30 Days)
  • RVMD 2.4M
  • VNT 1.2M
  • Earning Date
  • RVMD 11-05-2025
  • VNT 10-30-2025
  • Dividend Yield
  • RVMD N/A
  • VNT 0.27%
  • EPS Growth
  • RVMD N/A
  • VNT 4.02
  • EPS
  • RVMD N/A
  • VNT 2.73
  • Revenue
  • RVMD N/A
  • VNT $3,043,900,000.00
  • Revenue This Year
  • RVMD N/A
  • VNT $2.99
  • Revenue Next Year
  • RVMD $537.73
  • VNT $4.50
  • P/E Ratio
  • RVMD N/A
  • VNT $13.64
  • Revenue Growth
  • RVMD N/A
  • VNT 1.76
  • 52 Week Low
  • RVMD $29.17
  • VNT $27.22
  • 52 Week High
  • RVMD $65.98
  • VNT $43.88
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 84.78
  • VNT 34.18
  • Support Level
  • RVMD $58.91
  • VNT $36.90
  • Resistance Level
  • RVMD $63.15
  • VNT $38.32
  • Average True Range (ATR)
  • RVMD 2.19
  • VNT 1.22
  • MACD
  • RVMD 0.40
  • VNT -0.31
  • Stochastic Oscillator
  • RVMD 98.46
  • VNT 17.30

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.

Share on Social Networks: